Orion Corporation, Orion Pharma
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Finland
- Registered address
- Orionintie 1, Espoo, FI-02200, Finland (FIN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3003073605 · DUNS 539763727
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-11-07
- VAIDrug Quality Assurance2022-06-02
- VAIDrug Quality Assurance2020-09-17
- VAIDrug Quality Assurance2018-06-01
- VAIBioresearch Monitoring2017-04-21
- NAIDrug Quality Assurance2014-09-05
- VAIDrug Quality Assurance2012-12-20
- VAIDrug Quality Assurance2010-09-14
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- darolutamideBayer HealthCare Pharmaceuticals Inc.
- EntacaponeSun Pharmaceutical Industries, Inc.
- Methotrexate Sodiumin shortageSun Pharmaceutical Industries, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.